Navigation Links
RSB Spine, LLC, Announces European Patent Allowance
Date:11/15/2011

CLEVELAND, Nov. 15, 2011 /PRNewswire/ -- RSB Spine, LLC, today announced allowance of  European Patent 1847240 covering specific design iterations of its line of InterPlate® cervical and lumbar intervertebral fusion devices.

"Fusion remains one of the most common spinal procedures performed by neurosurgeons and orthopedic surgeons, despite the introduction of numerous disc replacement implants," commented James M. Moran, D. Eng., the company's chief technical officer. "This intellectual property reinforces RSB's freedom to respond to evolving surgeon preferences and supports our plans for European sales. Ongoing legal disputes also highlight the need for medical device companies to have the protection of a strong patent portfolio."

In July, the company received a United States Patent involving design of interbody devices that prevent stress shielding, complementing a previous European approval for the same concepts.

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: www.rsbspine.com and www.paradigmbiodevices.com.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
2. RSB Spine, LLC, Announces FDA Clearance for the InterPlate(R) C-Ti as an Anterior Cervical Plate
3. RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
4. Amedica® Corporation Acquires US Spine, Further Securing Its Leadership Position in the Spinal Device Marketplace
5. RSB Spine, LLC, Announces Record Third-Quarter 2010 Revenue and Offering Completion
6. RSB Spine, LLC, Announces Record 2010 Revenue Growth
7. RSB Spine, LLC, Announces Record First-Quarter 2011 Revenue
8. RSB Spine, LLC, Announces Record Second-Quarter 2011 Revenue
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Potrero Medical, Inc., ... pleased to announce the appointment of George M. Rapier, ... San Antonio, TX , WellMed is one of ... 200,000 patients and HMO members in Texas ... in 1990 out of his own internal medicine practice, he ...
(Date:2/11/2016)... , Feb. 11, 2016  NOIT™ Research LLC, a ... "Gift of Change" campaign to assist needy families in ... such unit sold between February 10, 2016 and March ... a needy family. The NOIT is an auditory stimulus ... individuals develop language skills. Beth Shier ...
(Date:2/11/2016)... , Feb. 11, 2016  MiMedx Group, Inc. ... utilizing human amniotic membrane and other birth tissues, human ... to develop and market advanced products and therapies, announced ... Markets, 2016 Global Healthcare Conference in New ... and CEO, Michael J. Senken , Chief Financial ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... , ... The president released a FY 2017 budget request on Tuesday that ... the cost burden to military beneficiaries. , MOAA’s president, retired Air Force Lt. ... including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We were ...
(Date:2/11/2016)... ... 2016 , ... The Chartis Group, a national advisory services ... the “2015/2016 Best in KLAS: Software and Services” report in two categories: IT ... insights firm on a global mission to improve healthcare delivery by amplifying the ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... to reverse diabetes has been gearing up for their simultaneous grand openings in ... It’s about right now that you’re probably wondering, is reversing diabetes possible? According ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... advocates will discuss how to improve care by making data on heart procedures ... disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital Heart ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader ... to announce the promotions of Allison Kelly to executive vice president of the ... vice president of North American capital sales, and Wendy Oseas to vice president ...
Breaking Medicine News(10 mins):